Trellus Management Company’s DermTech, Inc. Common Stock DMTK Stock Holding History

Trellus Management Company’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,352	Closed	-$137K	–	67
2023 Q1	$137K	Buy	+37,352	New	+$157K	0.16%	48
2022 Q1	–	Sell	-23,025	Closed	-$364K	–	68
2021 Q4	$364K	Hold	23,025	–	–	0.24%	47
2021 Q3	$739K	Hold	23,025	–	–	0.54%	46
2021 Q2	$957K	Hold	23,025	–	–	0.66%	38
2021 Q1	$1.17M	Sell	23,025 -3,500	-13%	-$183K	0.61%	31
2020 Q4	$860K	Buy	+26,525	New	+$376K	0.71%	39

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Trellus Management Company's DMTK Position: Q2 2023 in Review

Trellus Management Company sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 37,352 shares — an estimated $137K sold.

Trellus Management Company first reported a position in DMTK in Q4 2020 and held it in 6 quarters. The position peaked at $1.17M in Q1 2021. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

Trellus Management Company reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Trellus Management Company sold 37,352 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $137K.
Trellus Management Company first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Trellus Management Company's DermTech, Inc. Common Stock position peaked at $1.17M in Q1 2021.
85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Trellus Management Company's 13F filing for Q2 2023, filed 14 Jul 2023.